PREVIOUS
✖
Clinical Management Protocol of COVID-19
June 19 , 2020
1623 days
835
0
- The Union Health Ministry has recently included Remdesivir as a part of investigational therapy and updated Clinical Management Protocol of COVID-19 patients.
- The ministry has also added loss of taste and loss of smell as two key symptoms of COVID-19 infection.
- Under the updated protocol, the Ministry has removed its earlier recommendation of the use of Hydroxychloroquine (HCQ) in severe cases.
- Also, the usage of HCQ along with Azithromycin was also removed.
Leave a Reply
Your Comment is awaiting moderation.